Immunotherapy

Researchers have harnessed the cancer-destroying abilities of the body’s natural killer cells. Nanodrones selectively target a tumor, enabling the killer cells suppress cancer growth, opening the door to novel, cancer-specific immunotherapies.

Moderna has announced results of a Phase 2b trial of its mRNA treatment for skin cancer. When paired with immunotherapy, the treatment significantly reduced risks of recurrence, metastasis and death, paving the way for trials against other cancers.

In what has already been tagged as a “game-changer” for cancer treatment, the potent once-a-day tablet known as divarasib has continued to impress at Phase 1b trial stage, outperforming not just current therapies but its previous trial results.

A study has found that a fatty acid found in meat and dairy may boost the cancer-killing abilities of the immune system’s T cells. Also found to enhance the effectiveness of immunotherapy, the nutrient could be used to complement cancer treatments.

A Phase 2 clinical trial of immunotherapy drug tarlatamab, produced promising results in patients with small cell lung cancer, a particularly aggressive form of cancer, for whom previous treatments haven't worked.

Researchers have developed a liquid gel that solidifies when injected into a solid tumor, is visible on a CT scan, and can slow-release cancer-fighting treatments. Combining the gel with immunotherapy improved survival in treatment-resistant cancers.

Immunotherapy is a promising cancer treatment, but it can take too long. In a new study, scientists have taken steps towards an “off-the-shelf” therapy that could be mass produced and quickly rolled out to patients with a variety of cancer types.

Cancer vaccines are a medical holy grail – but what if you could repurpose a vaccine you’ve already had? Scientists have demonstrated in mice a way to trick the immune system into attacking tumors by mistaking them for a pathogen it already targets.

Researchers have found that administering under-the-tongue immunotherapy given to young peanut-allergic children is a safe and effective way of desensitizing them to the food. It may provide another method of curbing this potentially deadly allergy.

Each year, more than 150,000 Americans are diagnosed with bowel cancer, or colorectal cancer, and the disease has a dire survival rate if surgery isn’t successful. Scientists now believe they have found one tiny molecule that could change all that.

Around 1.6 million Americans live with inflammatory bowel disease, dealing with persistent and debilitating relapses. Scientists have identified how a specialized subset of T cells falter in flare-ups, and they may hold they key to long-term recovery.

Scientists have discovered an unknown type of immune cell in people who've successfully beat cancer. These home in on multiple targets at once, preventing new tumors forming for up to a year later and could lead to more effective cancer therapies.